Thermo Fisher ( NYSE: TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data ...

Key drivers of this growth include the increasing number of decentralized clinical trials, the rising adoption ...

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

Key opportunities in the clinical trial platform market include leveraging AI and machine learning for enhanced trial design ...

Waystar finalized its acquisition of artificial-intelligence-driven revenue cycle management company Iodine Software, its first acquisition since going public last year. Waystar, a healthcare payment ...

Neocis®, the leader in robotic-assisted dental surgery, today announced new clinical data highlighting the significant ...

Beta Bionics, Inc. (($BBNX)) announced an update on their ongoing clinical study. Beta Bionics, Inc. has initiated a clinical study titled ‘iLet ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion in cash and ...

One analysis showed participant costs were substantially lower – 8% below an employer client's general adult population and ...

Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in ...

US-based software company Suvoda has launched a unified ... revealed that 63% of global trial subjects consider a smartphone app for data collection as helpful. Suvoda product management director ...

The healthcare industry is experiencing a fundamental transformation — a shift from the traditional fee-for-service model to ...